ArticleOncotarget2014

Selenocysteine derivative overcomes TRAIL resistance in melanoma cells: evidence for ROS-dependent synergism and signaling crosstalk.

Wenqiang Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.